Endonovo acquires Rio Grande Neurosciences for M

Endonovo Therapeutics (OTCQB:ENDV -7%) acquires privately held Santa Fe, NM-based Rio Grande Neurosciences for $30M in cash, stock and assumption of debt. Rio Grande develops non-invasive brain stimulation technologies called Electroceuticals. Endonovo’s two technology platforms are Immunotronics, a non-invasive, non-implantable bioelectric device for treating/preventing organ failure through the reduction of inflammation and necrosis, and Cytotronics, a method for expanding and manipulating cells using simulated microgravity and Time-Varying Electromagnetic Fields for tissue engineering and cell therapies.

Link to Full Article: Endonovo acquires Rio Grande Neurosciences for M

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!